Bayer Ag · XETR:BAYN
Bayer — Investor Day (March 2024)
15 slides from Bayer's investor day presentation, Mar 5, 2024
Slide 1: Driving Sustainable Industry Leading Performance
BAYER Driving Sustainable Industry Leading Performance Capital Markets Day 2024 HEIKO SCHIPPER President of the Consumer Health Division
Slide 2: Cautionary statements regarding forward-looking information
. Cautionary statements regarding forward-looking information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the
Slide 3: The Consumer Health Market Continues to Remain Attractive
The Consumer Health Market Continues to Remain Attractive Category dynamics to settle again on a steady and attractive mid-single digit growth percentage INDUSTRY GROWTH OUTLOOK INDUSTRY GROWTH DRIVERS 3-5% Self-Care focus Healthcare systems overstretched Digital ecosystems & personalization CAGR CH
Slide 4: A Leading Player With a Well-Balanced Core Consumer Health Portfolio
A Leading Player With a Well-Balanced Core Consumer Health Portfolio C AT E G O R Y P O R T F O L I O GEOGRAPHIC FOOTPRINT NORTH AMERICA 3% Nutritionals 12% 23% EUROPE, MIDDLE Dermatology EAST & AFRICA Digestive Health ~38% 12% 2023 ~36% Allergy €6.0bn Pain ~13% 11% 24% ~13% Cough & Cold Cardiovascu
Slide 5: Iconic Brands With Leading Market Positions
Iconic Brands With Leading Market Positions #1 Cardio #1 Wound Care #2 Immunity #1 Healthy Baby #1 Women's Intimate Health #2 Heartburn EMEA #2 Allergy NA #2 Digestive Health EMEA #2 Constipation US #1 Nasal Cold US #1 Energy #1 Multivitamins NA Source: Market 360, MAT October 2023, Value, SAM - Str
Slide 6: Consistent Track Record in Delivering Profitable Growth and Cash
Consistent Track Record in Delivering Profitable Growth and Cash GROWTH ACCELERATED CONSTANT MARGIN EXPANSION IMPROVED CASH CONVERSION ABOVE MARKET DESPITE INFLATION DRIVEN BY LOWER WSR NET SALES €bn / GROW TH % 1 EBITDA 2 €bn / AS % OF NET SALES W ORKING CAPITAL AS % OF NET SALES 3 Net Sales 5.5 5.
Slide 7: A Clear Game Plan to Sustain Outperformance
A Clear Game Plan to Sustain Outperformance Help over 1 billion people to live healthier lives with most trusted // VISION self-care solutions // AMBITION Grow our brands ahead of market, achieve industry competitive EBITDA Winning Portfolio in attractive categories and geographies // WHERE TO PLAY
Slide 8: Growing our Brands and Innovating Across Four Growth Drivers
Growing our Brands and Innovating Across Four Growth Drivers Core Business Innovation Geographic Digital commerce on unmet needs expansion & access & health platforms Household penetration Rx-to-OTC Switch Brand expansion eCommerce Trial and awareness Holistic gut health India, ASEAN Digital Diagnos
Slide 9: Industry Leading Commercial Capabilities
Industry Leading Commercial Capabilities Creative Full funnel Leading eCommerce Customer and excellence precision marketing capabilities HCP centric mindset Best-in-class creativity Personalized Strategic acquisitions Strategic customer consumer experience in eCommerce partnerships in key markets To
Slide 10: Agile and Focused Organization with Dynamic Shared Ownership
Agile and Focused Organization with Dynamic Shared Ownership FROM TO Consumer & Customer Value creation through Functional Orientation Centric Teams speed & simplification ASEAN Dermatology & Allergy Impact Senior Management Walmart US Product Supply Commercial Marketing … Amazon Category Team Net S
Slide 11: Consumer Health as a Force for Good – and Growth
Consumer Health as a Force for Good – and Growth Expand Path to Access to Climate Everyday Neutrality Health with improved access reduction achieved to self-care in underserved across operations communities 2023 since 2019 Target: 100M in 2030 Target: climate neutral in 2030 12% of net sales from lo
Slide 12: A Sustainable Value Creation Model, Accelerated by DSO
A Sustainable Value Creation Model, Accelerated by DSO GROWTH Drive above-market growth focusing on attractive categories, markets, channels, and superior execution Sales Growth MARGIN Continuously improve margin through scale effects and continuous efficiency programs Dynamic Shared Ownership CASH
Slide 13: Mid-term Outlook Anticipates Above Market Sales Growth
Mid-term Outlook Anticipates Above Market Sales Growth Disciplined Execution of New Operating Model to Improve Profitability and Operating Cash Flows 2023 2024e Mid-Term at constant FX1 Sustainable Growth above market Investment for growth in attractive categories & geographies Net Sales €6.0bn +3%
Slide 14: Driving Sustainable Peer Outperformance in Consumer Health
Driving Sustainable Peer Outperformance in Consumer Health Further build iconic brands through innovation and commercial excellence Consistent track record of delivering growth, margin and cash expansion A Game Plan to sustain outperformance, industry leading capabilities Agile and focused organizat
Slide 15: Driving Sustainable Industry Leading Performance in Consumer Health
DRIVING SUSTAINABLE INDUSTRY LEADING PERFORMANCE I N C O N S U M E R H E A LT H 15 /// Bayer Capital Markets Day 2024 /// March 5, 2024 /// Consumer Health